BTIG upgraded Alector (ALEC) to Buy from Neutral with a $6 price target
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALEC:
- Buy Rating on Alector: Strategic Pivot to Blood–Brain-Barrier Platform and Emerging Alzheimer’s Assets AL137 and AL064 Underpins Attractive Risk–Reward
- Alector: Holding Amid Pipeline Setback as ABC Brain Delivery Platform Awaits Clinical Validation
- Alector reports Q4 EPS (34c), consensus (36c)
- Alector Ends Latozinemab Continuation Study: Reading the Signals for ALEC Investors